(E)-1-(5-Hy­droxy-2,2-dimethyl-2H-chromen-6-yl)-3-(3,4,5-trimeth­oxy­phen­yl)prop-2-en-1-one

por Wang, Guang-cheng, Yang, Ying-hong
Publicado 2011

2,2-Dimethyl-5-{[(4-nitro­phen­yl)amino]­methyl­idene}-1,3-dioxane-4,6-dione

por Yang, Ying-Hong, Li, Zi-Cheng, Luo, You-Fu
Publicado 2011

Breast Microinvasive Carcinoma With Different Morphologies: Analysis of Clinicopathologic Features of 121 Cases

por Feng, ChangYin, Zheng, QiaoLing, Yang, YingHong
Publicado 2020

5-[(2-Chloro-4-nitro­anilino)methyl­idene]-2,2-dimethyl-1,3-dioxane-4,6-dione

por Lan, Xian-Qiu, Zhang, Xiao-Feng, Yang, Ying-Hong, Luo, You-Fu
Publicado 2011

NMR-based metabolomics to select a surgical method for treating papillary thyroid carcinoma

por Wang, Bo, Zhang, Li-Yong, Wang, Si-Si, Yang, Ying-Hong, Zhao, Wen-Xin
Publicado 2018

Synthesis and Biological Evaluation of 2-(3-Fluoro-4-nitro phenoxy)-N-phenylacetamide Derivatives as Novel Potential Affordable Antitubercular Agents

por Ang, Wei, Lin, Yan-Ni, Yang, Tao, Yang, Jian-Zhong, Pi, Wei-Yi, Yang, Ying-Hong, Luo, You-Fu, Deng, Yong, Wei, Yu-Quan
Publicado 2012

Elevated Prevalence of Abnormal Glucose Metabolism and Other Endocrine Disorders in Patients with β-Thalassemia Major: A Meta-Analysis

por He, Li-Na, Chen, Wei, Yang, Yi, Xie, Ying-Jun, Xiong, Ze-Yu, Chen, Di-Yu, Lu, Dian, Liu, Neng-Qing, Yang, Ying-Hong, Sun, Xiao-Fang
Publicado 2019

Syntheses and Cell-Based Phenotypic Screen of Novel 7-Amino pyrido[2,3-d]pyrimidine-6-carbonitrile Derivatives as Potential Antiproliferative Agents

por Yang, Tao, He, Hong, Ang, Wei, Yang, Ying-Hong, Yang, Jian-Zhong, Lin, Yan-Ni, Yang, Hua-Cheng, Pi, Wei-Yi, Li, Zi-Cheng, Zhao, Ying-Lan, Luo, You-Fu, Wei, Yuquan
Publicado 2012

Prognostic significance of perigastric tumor deposits in patients with primary gastric cancer

por Anup, Shrestha, Lu, Jun, Zheng, Chao-Hui, Li, Ping, Xie, Jian-Wei, Wang, Jia-Bin, Lin, Jian-Xian, Chen, Qi-Yue, Cao, Long-Long, Lin, Mi, Yu, Qian, Yang, Ying-Hong, Huang, Chang-Ming
Publicado 2017

Correction: UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expression of PDK1 through PI3K/AKT signaling

por Lin, Jian-Xian, Xie, Xin-Sheng, Weng, Xiong-Feng, Qiu, Sheng-Liang, Yoon, Changhwan, Lian, Ning-Zi, Xie, Jian-Wei, Wang, Jia-Bin, Lu, Jun, Chen, Qi-Yue, Cao, Long-Long, Lin, Mi, Tu, Ru-Hong, Yang, Ying-Hong, Huang, Chang-Ming, Zheng, Chao-Hui, Li, Ping
Publicado 2023

UFM1 suppresses invasive activities of gastric cancer cells by attenuating the expres7sion of PDK1 through PI3K/AKT signaling

por Lin, Jian-Xian, Xie, Xin-Sheng, Weng, Xiong-Feng, Qiu, Sheng-Liang, Yoon, Changhwan, Lian, Ning-Zi, Xie, Jian-Wei, Wang, Jia-Bin, Lu, Jun, Chen, Qi-Yue, Cao, Long-Long, Lin, Mi, Tu, Ru-Hong, Yang, Ying-Hong, Huang, Chang-Ming, Zheng, Chao-Hui, Li, Ping
Publicado 2019

An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer

por Wang, Jia-Bin, Li, Ping, Liu, Xiao-Long, Zheng, Qiao-Ling, Ma, Yu-Bin, Zhao, Ya-Jun, Xie, Jian-Wei, Lin, Jian-Xian, Lu, Jun, Chen, Qi-Yue, Cao, Long-Long, Lin, Mi, Liu, Li-Chao, Lian, Ning-Zi, Yang, Ying-Hong, Huang, Chang-Ming, Zheng, Chao-Hui
Publicado 2020

m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer

por Lin, Jian-Xian, Lian, Ning-Zi, Gao, You-Xin, Zheng, Qiao-Ling, Yang, Ying-Hong, Ma, Yu-Bin, Xiu, Zhi-Song, Qiu, Qing-Zhu, Wang, Hua-Gen, Zheng, Chao-Hui, Li, Ping, Xie, Jian-Wei, Lu, Jun, Chen, Qi-Yue, Cao, Long-Long, Lin, Mi, Wang, Jia-Bin, Huang, Chang-Ming
Publicado 2022

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer

por Wang, Jia‐Bin, Qiu, Qing‐Zhu, Zheng, Qiao‐Ling, Zhao, Ya‐Jun, Xu, Yu, Zhang, Tao, Wang, Shuan‐Hu, Wang, Quan, Jin, Qin‐Wen, Ye, Yin‐Hua, Li, Ping, Xie, Jian‐Wei, Lin, Jian‐Xian, Lu, Jun, Chen, Qi‐Yue, Cao, Long‐Long, Yang, Ying‐Hong, Zheng, Chao‐Hui, Huang, Chang‐Ming
Publicado 2023

CDK5RAP3 inhibits angiogenesis in gastric neuroendocrine carcinoma by modulating AKT/HIF-1α/VEGFA signaling

por Lin, Jian-Xian, Weng, Xiong-Feng, Xie, Xin-Sheng, Lian, Ning-Zi, Qiu, Sheng-Liang, Wang, Jia-Bin, Lu, Jun, Chen, Qi-Yue, Cao, Long-Long, Lin, Mi, Tu, Ru-Hong, Yang, Ying-Hong, Liu, Si-Jia, Hu, Min, Lin, Yi-Ke, Huang, Chang-Ming, Zheng, Chao-Hui, Li, Ping, Xie, Jian-Wei
Publicado 2019